Table 1.
Pathway | Targets | Drugs | Reference |
---|---|---|---|
De novo synthesis | Serine palmitoyltransferase | Myriocin Fumifungin Lipoxamycin Hydroxylipoxamycin |
[81] [86] [82] |
Ceramide synthase | Fumonisin B1 | [5,87] | |
Dihydroceramide desaturase 1 | GT11 (C8-cyclopropenylceramide) XM462 (5-thiadihydroceramide) Fenretinide SKI II Celecoxib Resveratrol Curcumin Δ9-tetrahydrocannabinol (THC) |
[83] [84] [85] |
|
Sphingomyelin hydrolysis | Neutral sphingomyelinase | Scyphostatin Spiroexpoxide Manumycin A Alutenusin Ubiquinol |
[88] [89] [90] [91] [92] |
Salvage pathway | Acid sphingomyelinase | KARI 201 ARC39 AD2765 SMA-7 α-mangostin Cowanol and Cowanin L-αphosphatidyl-D-myoinositol-3,5-biphosphate Phosphatidyl-myo-inositol-3,4,5-triphosphate Fluoxetine Dextromethorphan Maprotilin Orphenadrine Nortriptyline Triflupromazine Sertraline |
[93] [94] [95] [96] [97] [85] [98] [99] [100] |